## DOCU: DocuSign, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.41 indicates fundamental undervaluation. Quality metrics strong (ROE 15%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($64.03)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. 1832 Asset Management L.P. Invests $1.80 Million in Docusign Inc. $DOCU**
- Source: MarketBeat | 20251207T084400 | Neutral | Relevance: 98%
- 1832 Asset Management L.P. established a new position in DocuSign during the second quarter, purchasing 23,100 shares valued at approximately $1.80 million. Despite this new investment and DocuSign beating Q2 EPS estimates with an 8.8% year-over-year revenue increase, company insiders have been net sellers, offloading 104,076 shares in the past 90 days. Analysts maintain a "Hold" rating for DOCU, with an average price target of $86.71 compared to its current trading price near $65.67.

**2. WINTON GROUP Ltd Takes Position in Docusign Inc. $DOCU**
- Source: MarketBeat | 20251208T131016 | Neutral | Relevance: 97%
-  WINTON GROUP Ltd has acquired a new position in Docusign Inc. (NASDAQ:DOCU), purchasing 68,184 shares valued at approximately $5.31 million during the second quarter. The investment comes as DocuSign reported Q2 earnings exceeding expectations, with $0.92 EPS against an expected $0.84 and revenue of $800.64 million, marking an 8.8% year-over-year increase. Despite institutional interest, the stock faces lukewarm analyst sentiment and recent insider selling.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 8)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Piper Sandler | $75 | $90 | -17% |
| 2025-12-05 | UBS | $75 | $85 | -12% |
| 2025-12-05 | Evercore ISI Gr | $80 | $92 | -13% |
| 2025-12-05 | Wells Fargo | $75 | $85 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | UBS | main | Neutral |
| 2025-12-05 | Evercore ISI Gr | main | In-Line |
| 2025-12-05 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.01M) |
| Sells | 27 ($3.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 4 |

**Top Holders:**
- Blackrock Inc.: 11.7% (-2.8%)
- Vanguard Group Inc: 10.8% (+1.1%)
- State Street Corpora: 4.0% (+0.5%)
- Jericho Capital Asse: 2.4% (0.0%)
- Capital World Invest: 2.1% (+0.2%)

### Key Risks

1. Insider selling cluster: $3.5M in recent transactions.
2. Long-term trend broken: trading 9.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.41 indicates undervaluation relative to growth. Analyst sentiment negative (8 target cuts vs 0 raises). Insider selling cluster ($3.5M in 90 days), potential headwind. Institutional flow bearish (4 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $14.0B |
| Beta | 0.99 |
| 52W Range | $63.41 - $101.31 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.41 |
| Forward P/E | 16.8 |
| Current P/E | 18.4 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.1% to 0.6% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.4pp (needs >4.0% for momentum thesis). MRS_5 at 1.0% confirms short-term momentum alignment. Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 52. Elevated volume (2.5x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.64% (CS: 64) | Neutral |
| RSI_14 | 52.0 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.003x | Above |
| vs SMA200 | 0.901x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $69.39
- **Stop Loss:** $64.03 (7.7% risk)
- **Target:** $80.11 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 223
- **Position Value:** $15,473.97
- **Portfolio %:** 15.47%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-03-12 (Est: $0.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.92 | $1.01 | +10.3% |
| 2025Q3 | $0.85 | $0.92 | +8.6% |
| 2025Q2 | $0.81 | $0.90 | +10.4% |
| 2025Q1 | $0.85 | $0.86 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*